Search research articles
Contact Us
Filters
Showing results (211-220 of 703) with videos related to
Page
of 71
Sort By:
Frontiers in Molecular Biosciences
|
June 6, 2022
Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma
Zarwa Yaseen, Tuba N Gide, Jordan W Conway, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 20, 2020
Response to Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes"
Venessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
Pigment Cell & Melanoma Research
|
June 23, 2016
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy
Benjamin Y Kong, Alexander M Menzies, Catherine A B Saunders, et al.
Cancer Cell International
|
November 26, 2025
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma
Fei Yang, Su Yin Lim, Ines Pires da Silva, et al.
Molecular Cancer Therapeutics
|
May 8, 2015
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
Nicholas Theodosakis, Matthew A Held, Alexander Marzuka-Alcala, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 22, 2022
Feasibility, acceptability, and utility of a nurse-led survivorship program for people with metastatic melanoma (MELCARE)
Julia Lai-Kwon, Brooke Kelly, Sarah Lane, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 3, 2019
Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes
Venessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Acute Radiation Skin Toxicity Associated With BRAF Inhibitors
Trish Pulvirenti, Angela Hong, Arthur Clements, et al.
BMJ Open
|
March 25, 2025
While they wait: a cross-sectional survey on wait times for mental health treatment for anxiety and depression for adolescents in Australia
Mirjana Subotic-Kerry, Thomas Borchard, Belinda Parker, et al.
Pigment Cell & Melanoma Research
|
April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression
Georgina V Long, James S Wilmott, Lauren E Haydu, et al.
Page
of 71
Search research articles
Search
Showing results (211-220 of 703) with videos related to
Sort By:
Page
of 71
Frontiers in Molecular Biosciences
|
June 6, 2022
Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma
Zarwa Yaseen, Tuba N Gide, Jordan W Conway, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 20, 2020
Response to Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes"
Venessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
Pigment Cell & Melanoma Research
|
June 23, 2016
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy
Benjamin Y Kong, Alexander M Menzies, Catherine A B Saunders, et al.
Cancer Cell International
|
November 26, 2025
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma
Fei Yang, Su Yin Lim, Ines Pires da Silva, et al.
Molecular Cancer Therapeutics
|
May 8, 2015
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume
Nicholas Theodosakis, Matthew A Held, Alexander Marzuka-Alcala, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 22, 2022
Feasibility, acceptability, and utility of a nurse-led survivorship program for people with metastatic melanoma (MELCARE)
Julia Lai-Kwon, Brooke Kelly, Sarah Lane, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 3, 2019
Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes
Venessa H M Tsang, Rachel T McGrath, Roderick J Clifton-Bligh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Acute Radiation Skin Toxicity Associated With BRAF Inhibitors
Trish Pulvirenti, Angela Hong, Arthur Clements, et al.
BMJ Open
|
March 25, 2025
While they wait: a cross-sectional survey on wait times for mental health treatment for anxiety and depression for adolescents in Australia
Mirjana Subotic-Kerry, Thomas Borchard, Belinda Parker, et al.
Pigment Cell & Melanoma Research
|
April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression
Georgina V Long, James S Wilmott, Lauren E Haydu, et al.
Page
of 71